Our findings indicate a crucial role for ERβ in UCB, including a novel stage-independent association with aggressive cancer histology and poor survival outcomes after cystectomy, and suggest clinical utility of ERβ pharmacologic targeting in this disease. Here, ESR2 is linked to cancer.